In our multivariate analysis, we identified younger age, WBC count ≥50, FLT3-ITD, and mutated WT1 as independent predictors of a poor outcome, and mutated NPM1 and GATA2 as independent predictors of favorable outcome in NK-AML. The gene discussed is NPM1; the disease is acute myeloid leukemia.